Skip to main content

Krystal Biotech

Pittsburgh, United States

Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..

$160.0M raised
May 2023
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Krystal Biotech

How much funding has Krystal Biotech raised?
Krystal Biotech has raised $160.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2023.
Who are Krystal Biotech's investors?
Krystal Biotech's investors include Redmile Group, Frazier Life Sciences, Frazier Healthcare Partners, Avoro Capital Advisors, Sun Pharmaceutical.
Where is Krystal Biotech headquartered?
Krystal Biotech is headquartered in Pittsburgh, United States.
What does Krystal Biotech do?
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
What stage is Krystal Biotech at?
Krystal Biotech is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Krystal Biotech — Funding & Investors." VCBacked, May 21, 2023, https://www.vcbacked.co/company/krystal-biotech. Accessed July 2, 2026.
APA
VCBacked. (2023). Krystal Biotech — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/krystal-biotech
Wikipedia (cite web)
{{cite web |title=Krystal Biotech — Funding & Investors |url=https://www.vcbacked.co/company/krystal-biotech |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .